Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Maumee OH, Akron OH, July 16, 2018 (GLOBE NEWSWIRE) -- Hundreds more Ohio families touched by autism spectrum disorder (ASD) and other developmental delays will have access to life-changing care now...
-
NEW YORK, July 16, 2018 (GLOBE NEWSWIRE) -- Deborah Barnes, Licensed Clinical Social Worker, has been selected to join the Industry Board at the American Health Council. She will be sharing her...
-
Inter-agency collaboration among BARDA, DTRA, USAMRIID and Spero to fund further clinical development of product candidate SPR994Planned pivotal Phase 3 trial of SPR994 on track to initiate around...
-
- First therapy specifically approved for smallpox advances health security against a significant bioterror threat-- Company Granted Priority Review Voucher - NEW YORK, July 13, 2018 (GLOBE...
-
Portland, Oregon, USA, July 13, 2018 (GLOBE NEWSWIRE) -- Kathryn Sweas, a scientifically validated energy healer, today announces the impact of a biofield energy treated proprietary nutraceutical...
-
Helsinki, Finland, July 13, 2018 (GLOBE NEWSWIRE) -- Carola Marina Sand, an evidence-based healer, today released research results from preclinical trials on the beneficial impact of biofield energy...
-
New York, NY, July 13, 2018 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Digital Health Market by Product Type [Healthcare Information Systems (Clinical Solutions and...
-
Newark, NJ, July 13, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced the appointment of Eric Van Cutsem...
-
London, United Kingdom, July 13, 2018 (GLOBE NEWSWIRE) -- Maire Mayne, an evidence-based energy healer, today announces research results on the impact of a biofield energy treated nutraceutical to...
-
SEATTLE, July 13, 2018 (GLOBE NEWSWIRE) -- Atossa Genetics Inc. (ATOS) (“Atossa” or the “Company”), a clinical-stage pharmaceutical company developing novel therapeutics and delivery methods to...